Olenox Industries to restate 2025 quarters
Rhea-AI Filing Summary
Olenox Industries Inc. reported that its independent auditors advised on July 31, 2026 that the unaudited condensed consolidated financial statements in its 2025 quarterly reports for March 31, June 30, and September 30 are materially incorrect and should not be relied upon. On August 3, 2026, authorized officers reached the same conclusion.
The issue stems from the merger with New Asia Holdings, Inc., where 4,000,000 shares of Series A Preferred Stock were issued as consideration. The acquisition-date fair value of these shares has been recalculated at $18,800,000 instead of the previously recorded $34,569,600, reducing consideration transferred, goodwill, and related stockholders’ equity by $15,769,600. The company states that net loss, loss per share, cash flows, and working capital for the affected periods are unchanged, and it plans to file amended quarterly reports after completion and auditor review of the restated financial statements.
Positive
- None.
Negative
- Olenox determined that three 2025 quarterly financial statements are materially incorrect, reducing merger consideration, goodwill and equity by $15,769,600 and requiring restated filings for those periods.
Filing Explained
The corrections remain in process: Olenox requested that the auditors who identified the issue provide the SEC a letter stating whether they agree with the disclosure, and says any such letter will accompany an amendment to this 8-K; the amended quarterly reports await completion and independent-auditor review.
8-K Event Classification
Key Figures
Key Terms
ASC 805 financial
Business Combinations financial
ASC 250 financial
Accounting Changes and Error Corrections financial
acquisition-date fair value financial
unaudited condensed consolidated financial statements financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Olenox Industries (OLOX) disclose about its 2025 financial statements?
Which reporting periods are affected by the Olenox (OLOX) restatement?
What caused the accounting error Olenox (OLOX) is correcting?
How much did Olenox (OLOX) change the fair value of the merger consideration?
Does the Olenox (OLOX) restatement affect net loss or cash flows?
What steps will Olenox (OLOX) take following the error in its 2025 quarters?
AI-generated analysis. How Rhea-AI works. Not financial advice.